Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-04-12 @ 1:09 AM
Study NCT ID:
NCT04678505
Status:
TERMINATED
Last Update Posted:
2022-11-04
First Post:
2020-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
3402-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None